Hairy cell leukaemia: biological and clinical overview from immunogenetic insights
- 2 November 2010
- journal article
- review article
- Published by Wiley in Hematological Oncology
- Vol. 29 (2) , 55-66
Abstract
Hairy cell Leukaemia (HCL) is a rare neoplasm of peripheral B cells which represents a paradox in oncology. Despite its largely unknown origin and behaviour, HCL is one of the few example of dramatic success in the treatment of a malignancy. The recent steps forward to understanding the biology of HCL from immunogenetic and genomic studies have recently provided new insight into diagnosis and prognosis. Several data from immunoglobulin gene (IG) analysis have provided hints regarding the cell of origin and the ongoing selective interactions of the tumour BCR with environmental stimuli. It has also recently emerged that an unmutated status of the HCL IG can be associated with failure to respond to cladribine, genetic abnormalities indicative of poor outcome and aggressive disease. These observations suggest a central role of the tumour B‐cell receptor in defining the outcome of HCL and that that IG gene analysis may have biological and prognostic relevance. Hopefully, IG analysis will help tailor treatment strategies for the most aggressive cases. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 124 references indexed in Scilit:
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010
- Effector and regulatory B cells: modulators of CD4+ T cell immunityNature Reviews Immunology, 2010
- VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapyBlood, 2009
- Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell LeukemiaJournal of Clinical Oncology, 2009
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Lymphocyte development: overviewCurrent Opinion in Immunology, 2008
- Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3Blood, 2008
- Immunotoxins for targeted cancer therapyThe AAPS Journal, 2006
- Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed PhenotypesPLOS Genetics, 2005
- Hairy cell leukemia: at the crossroad of somatic mutation and isotype switchBlood, 2004